Vaccine Response Impaired Clinical Trial
Official title:
Immune-Related Trafficking and Signaling in Human Skin Associated With Low-Power, Infrared Laser Treatment
NCT number | NCT02453113 |
Other study ID # | 20151840 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 2015 |
Est. completion date | January 2019 |
Verified date | October 2022 |
Source | University of California, Irvine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this is that the researcher can use low power Near Infrared laser treatment non-painful and non-damaging dose to changes the skin properties.The researcher can prove that signaling and a significant increase in the number of skin cells in skin tissue exposed to the laser can improve the human skin immune system to help improve human body response to vaccines.
Status | Completed |
Enrollment | 10 |
Est. completion date | January 2019 |
Est. primary completion date | January 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: - Adult men and women with skin type 1 and 2 - Not pregnant Exclusion Criteria: - Use of systemic steroids, topical steroids, tanning solutions and anticoagulant - History of HIV, mentally incompetent, prisoner, alcohol or drug impairment - Abnormal photosensitivity |
Country | Name | City | State |
---|---|---|---|
United States | Vaccine and Immunotherapy Center Massachusetts General Hospital | Charlestown | Massachusetts |
United States | Beckman Laser Institute | Irvine | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Irvine | Beckman Laser Institute University of California Irvine, Massachusetts General Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Skin Tissue Response to a Vaccine | Change in inflammatory cells with low level laser will be measured. | up to 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05060991 -
Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients
|
Phase 4 | |
Active, not recruiting |
NCT01446978 -
Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs
|
Phase 2 | |
Completed |
NCT03855176 -
Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients
|
Phase 4 | |
Not yet recruiting |
NCT05923970 -
Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?
|
||
Recruiting |
NCT05019248 -
Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving Cladribine
|
||
Completed |
NCT03467074 -
Role of Interferon-λ and Vaccine Response
|
||
Completed |
NCT05124509 -
Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant
|
||
Completed |
NCT05791851 -
Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders
|
||
Completed |
NCT05030974 -
RECOVAC Repeated Vaccination Study
|
Phase 4 | |
Completed |
NCT03930017 -
Pregnancy, Arsenic and Immune Response
|
||
Completed |
NCT05116748 -
COVID19 Vaccine in SOT Adult Recipients
|
||
Recruiting |
NCT06148025 -
Antibiotics and Vaccine Immune Responses Study
|
Phase 4 | |
Completed |
NCT03368495 -
Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines
|
Phase 4 | |
Completed |
NCT04059991 -
Antibodies in Repeated Influenza Vaccination (ARIVA) Study
|
||
Completed |
NCT04915820 -
Iron and COVID-19 Vaccine Response
|
N/A | |
Completed |
NCT04912661 -
Iron and Vaccine Response
|
N/A | |
Completed |
NCT04885907 -
Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients
|
Phase 4 | |
Completed |
NCT03588013 -
Study of Environmental Enteropathy and Malnutrition in Pakistan
|
N/A | |
Completed |
NCT04936997 -
Immune Response to the COVID-19 Vaccine
|
Early Phase 1 | |
Completed |
NCT03996538 -
Vaccination Efficacy With Metformin in Older Adults
|
Phase 1 |